Revolution Medicines Inc’s recent filing unveils that its insider GOLDSMITH MARK A unloaded Company’s shares for reported $0.45 million on Jun 17 ’24. In the deal valued at $37.39 per share,11,950 shares were sold. As a result of this transaction, GOLDSMITH MARK A now holds 311,885 shares worth roughly $12.11 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Wei Lin sold 5,589 shares, generating $208,954 in total proceeds. Upon selling the shares at $37.39, the Chief Medical Officer now owns 70,851 shares.
Before that, Horn Margaret A sold 4,415 shares. Revolution Medicines Inc shares valued at $165,064 were divested by the Chief Operating Officer at a price of $37.39 per share. As a result of the transaction, Horn Margaret A now holds 136,651 shares, worth roughly $5.31 million.
Needham reiterated its Revolution Medicines Inc [RVMD] rating to a Buy in a research note published on April 12, 2024; the price target was $46. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in early April from “an Outperform” to “a Strong buy”. Piper Sandler began covering RVMD with “an Overweight” recommendation on March 11, 2024. BofA Securities revised its rating on January 05, 2024. It rated RVMD as “a Buy” which previously was an “a Neutral”.
Price Performance Review of RVMD
On Tuesday, Revolution Medicines Inc [NASDAQ:RVMD] saw its stock jump 0.86% to $38.83. Over the last five days, the stock has gained 4.66%. Revolution Medicines Inc shares have risen nearly 35.39% since the year began. Nevertheless, the stocks have risen 52.16% over the past one year. While a 52-week high of $41.21 was reached on 06/03/24, a 52-week low of $15.44 was recorded on 01/18/24. SMA at 50 days reached $38.17, while 200 days put it at $30.26. A total of 0.93 million shares were traded, compared to the trading of 3.72 million shares in the previous session.
Levels Of Support And Resistance For RVMD Stock
The 24-hour chart illustrates a support level at 38.45, which if violated will result in even more drops to 38.06. On the upside, there is a resistance level at 39.23. A further resistance level may holdings at 39.62. The Relative Strength Index (RSI) on the 14-day chart is 51.86, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.51, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 48.58%. Stochastics %K at 44.08% indicates the stock is a holding.
The most recent change occurred on January 04, 2024 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $41 price target.
